Wiley Bros. Aintree Capital, LLC Amgen Inc Transaction History
Wiley Bros. Aintree Capital, LLC
- $2.26 Billion
- Q2 2024
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Amgen Inc stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 40,879 shares of AMGN stock, worth $13.1 Million. This represents 0.57% of its overall portfolio holdings.
Number of Shares
40,879
Previous 9,055
351.45%
Holding current value
$13.1 Million
Previous $2.57 Million
396.19%
% of portfolio
0.57%
Previous 0.36%
Shares
12 transactions
Others Institutions Holding AMGN
# of Institutions
3,052Shares Held
409MCall Options Held
7.19MPut Options Held
6.26M-
Vanguard Group Inc Valley Forge, PA51.9MShares$16.6 Billion0.32% of portfolio
-
Black Rock Inc. New York, NY46MShares$14.8 Billion0.33% of portfolio
-
State Street Corp Boston, MA29MShares$9.29 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA14.4MShares$4.63 Billion3.32% of portfolio
-
Morgan Stanley New York, NY14.4MShares$4.6 Billion0.35% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $171B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...